Keciany Alves de Oliveira

Prof. Dr. Keciany Alves de Oliveira

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
ABAna Clara Vital Batista
Ana Clara Vital Batista
MRMariana de Alencar Ribeiro
Mariana de Alencar Ribeiro
KOKeciany Alves de Oliveira
Keciany Alves de Oliveira
PFPaula Alexandre de Freitas
Paula Alexandre de Freitas
NSNeucilane Silveira dos Santos
Neucilane Silveira dos Santos
AOAriclécio Cunha de Oliveira
Ariclécio Cunha de Oliveira

20 December 2022 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
PDF file
GSGermana Asfor Carvalho Souza
Germana Asfor Carvalho Souza
CMCarla Soraya Costa Maia
Carla Soraya Costa Maia
KOKeciany Alves de Oliveira
Keciany Alves de Oliveira
RBRibanna Aparecida Marques Braga
Ribanna Aparecida Marques Braga
ESEdson Silva Soares
Edson Silva Soares
ALAdriano César Carneiro Loureiro
Adriano César Carneiro Loureiro

1 January 2021 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
ACAndrelina N. Coelho-De-Souza
Andrelina N. Coelho-De-Souza
RAR. Alves-Soares
R. Alves-Soares
HOH.D. Oliveira
H.D. Oliveira
YGYuri de Abreu Gomes-Vasconcelos
Yuri de Abreu Gomes-Vasconcelos
PSP.J.C. Souza
P.J.C. Souza
JLJosé Henrique Leal-Cardoso
José Henrique Leal-Cardoso
Hyptis crenata, commonly known as “salva-do-Marajó”, “hortelã-do-campo”, and “hortelãzinha”, is used in folk medicine in Northeast Brazil as tea or infusion to treat inflammatory diseases. Due to the pharmacological efficacy and the low toxicity of the essential oil of Hyptis crenata (EOHc), we decided to investigate the EOHc antiedematogenic effect in experimental models of inflammation. EOHc was administrated orally at doses of 10-300 mg/kg to male Swiss albino mice. Paw edema was induced by subcutaneous injection in the right hind paw of inflammatory stimuli (carrageenan, dextran, histamine, serotonin, and bradykinin) 60 min after administration of EOHc. EOHc significantly inhibited the induced edema. The inhibitory effect of EOHc on dextran-induced edema extended throughout the experimental time. For the 30, 100, and 300 mg/kg doses of EOHc, the inhibition was of 40.28±1.70, 51.18±2.69, and 59.24±2.13%, respectively. The EOHc inhibitory effect on carrageenan-induced edema started at 10 mg/kg at the second hour (h) and was maintained throughout the observation period. At 30, 100, and 300 mg/kg doses the inhibition started earlier, from 30 min. At the edema peak of 180 min, 56, 76, and 82% inhibition was observed for 30, 100, and 300 mg/kg doses, respectively. Additionally, the effect of EOHc on carrageenan-induced paw edema was influenced by the time of administration. The EOHc also inhibited myeloperoxidase activity. In conclusion, the EOHc showed a potent effect, both preventing and reversing the edema, consistent with its anti-inflammatory use in folk medicine.

1 January 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
KOKeciany Alves de Oliveira
Keciany Alves de Oliveira
MGMaria Diana Moreira Gomes
Maria Diana Moreira Gomes
RVRenata Prado Vasconcelos
Renata Prado Vasconcelos
EAEwerton Sousa de Abreu
Ewerton Sousa de Abreu
RFRodrigo Soares Fortunato
Rodrigo Soares Fortunato
AOAriclecio Cunha de Oliveira
Ariclecio Cunha de Oliveira
Phytomodulatory proteins from the latex of the medicinal plant Calotropis procera has been shown to be implicated in many pharmacological properties. However there is no current information about their activity on glucose metabolism, although the latex is used in folk medicine for treating diabetes. In this study the phytomodulatory proteins (LP) from C. procera latex were assessed on glycemic homeostasis. Control animals received a single intravenous dose (5 mg/kg) of LP or saline solution (CTL). Four hours after treatment, the animals were euthanized and their livers were excised for analysis by western blot and RT-PCR AMP-activated protein kinase (AMPK), phosphoenolpyruvate carboxykinase (PEPCK) and tumor necrosis factor alpha (TNF-α). In vivo tests of intraperitoneal tolerance to insulin, glucose and pyruvate were also performed, and the effect of LP administration on fed glycemia was studied followed by blood analysis to determine serum insulin levels. Treatment with LP reduced glycemia two hours after glucose administration (LP: 87.2 ± 3.70 mg/dL versus CTL: 115.6 ± 8.73 mg/dL). However, there was no change in insulin secretion (CTL: 14.16 ± 0.68 mUI/mL and LP: 14.96 ± 0.55 mUI/mL). LP improved the insulin sensitivity, represented by a superior glucose decay constant during an insulin tolerance test (kITT) (4.17 ± 0.94%/min) compared to the CTL group (0.82 ± 0.72%/min), and also improved glucose tolerance at 30 min (105.2 ± 12.4 mg/dL versus 154.2 ± 18.51 mg/dL), while it decreased hepatic glucose production at 15 and 30 min (LP: 75.5 ± 9.31 and 52.5 ± 12.05 mg/dL compared to the CTL: 79.0 ± 3.02 and 84.5 ± 7.49 mg/dL). Furthermore, there was a significant inhibition of gene expression of PEPCK (LP: 0.66 ± 0.06 UA and CTL: 1.14 ± 0.22 UA) and an increase of phosphorylated AMPK (LP: 1.342 ± 0.21 UA versus CTL: 0.402 ± 0.09 UA). These findings confirm the effect of LP on glycemic control and suggest LP may be useful in diabetes treatment. However, the pharmacological mechanism of LP in PEPCK modulation still needs more clarification.

1 March 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
MPMarcos Freitas Pereira
Marcos Freitas Pereira
ISIgor de Codes Soares
Igor de Codes Soares
MCMarília Magalhães Cabral
Marília Magalhães Cabral
PFPaula Alexandre de Freitas
Paula Alexandre de Freitas
GSGabriel Sousa
Gabriel Sousa
KOKeciany Alves de Oliveira
Keciany Alves de Oliveira
Background/Objectives: Yacon syrup (Smallanthus sonchifolius) has gained attention due to its high concentration of fructooligosaccharides (FOSs) and associated health benefits. This systematic review aimed to evaluate the effects of yacon syrup on metabolic parameters and intestinal health in humans over the last decade. Methods: Following PRISMA guidelines, we conducted a systematic search in databases, including Medline (PubMed), Science Direct, Embase, Scopus, and SciELO, up to October 2024. Inclusion criteria focused on clinical trials examining the impact of yacon syrup on glycemic control, lipid profile, insulin sensitivity, appetite regulation, and gut microbiota in healthy, overweight, or obese individuals. Seven studies met the inclusion criteria, encompassing 161 participants from diverse populations. Results: Yacon syrup supplementation demonstrated significant reductions in fasting insulin, HOMA-IR, and LDL cholesterol, alongside improvements in satiety and intestinal transit time. Acute supplementation with yacon syrup had inconsistent results for postprandial glycemia and insulin levels, probably due to prior individual gut microbiota composition. Longer interventions with yacon syrup were associated with enhanced microbiota modulation and appetite regulation, particularly in women. Mild gastrointestinal discomfort was reported, but with the continued use of yacon syrup, the symptoms decreased. Yacon syrup presents promising health benefits, including improved insulin sensitivity, weight management, and gut health. However, further research is needed to establish optimal dosing and long-term safety. Conclusions: This review highlights the potential of yacon syrup as a functional supplement for metabolic and gastrointestinal health.

1 August 2024 in Applied Physiology, Nutrition, and Metabolism
Verified
Journal Article
Closed access
VOVictor Hugo Ortenzi
Victor Hugo Ortenzi
AOAriclecio Cunha de Oliveira
Ariclecio Cunha de Oliveira
RVRenata Prado Vasconcelos
Renata Prado Vasconcelos
MNMarcelo Barbosa Neves
Marcelo Barbosa Neves
ATAyla Josma Teixeira
Ayla Josma Teixeira
RFRodrigo Soares Fortunato
Rodrigo Soares Fortunato
Sex differences in metabolic dysfunction-associated steatotic liver disease (MASLD) have been reported. Oxidative stress and inflammation are involved in the progression of MASLD. Thus, we aimed to evaluate liver redox homeostasis and inflammation in male and female rats fed a high-fat diet (HFD). Male and female Wistar rats were divided into the following groups: standard chow diet (SCD) or HFD during 12 weeks. HFD groups of both sexes had higher hepatocyte injury, with no differences between the sexes. Portal space liver inflammation was higher in females-HFD compared to females-SCD, whereas no differences were observed in males. Lobular inflammation and overall liver inflammation were higher in HFD groups, regardless of sex. TNF-α, IL-6, and IL-1β levels were higher in males-HFD compared to males-SCD, but no differences were observed in females. Catalase activity was higher in males compared to females, with no differences between the SCD and HFD groups of both sexes. Glutathione peroxidase activity was higher in females compared to males, with no differences between the SCD and HFD groups in both sexes. Lipid peroxidation was higher in female-SCD when compared to male-SCD, and in both male- and female-HFD compared to SCD groups. Furthermore, both cytoplasmic and nuclear NRF2 staining were lower in the HFD group compared to the SCD group in males. However, female-HFD exhibited reduced nuclear NRF2 staining compared to the female-SCD group. In conclusion, our study demonstrated that while both male and female rats developed metabolic dysfunction-associated steatohepatitis after 12 weeks of HFD, the alterations in inflammatory cytokines and redox balance were sexually dimorphic.